Rentokil Initial: Shares Appealing As Weak Pest Control Sales Offer an Attractive Entry Point
Investors were disappointed by decidedly weak third-quarter organic revenue growth of 2.3% for Rentokil RTO Initial’s pest control category—the group’s largest category, accounting for 94% of total operating profit following the recent Terminix acquisition. Tepid demand for pest control services in North America—the pest control business’ most important geography, accounting for 75% of pest control sales—and a contraction in wholesale pest control product distribution sales drove the soft result. Elsewhere, Rentokil’s hygiene and wellbeing category delivered robust third-quarter organic sales growth of 5.7%, which tracks our full-year expectations.
While we’d expected organic growth for the pest control business would moderate in late 2023—from an elevated 5.6% in the first half of 2023—conditions in North America have deteriorated more sharply than we’d previously credited. As a result, we lower our full-year EBIT and EPS forecasts by a respective 2% and 3% to GBP 913 million and GBP 0.23. Still, we think investors—who have sent shares some 15% lower as of the time of writing—have overreacted to the softened performance of the pest control category in late 2023. With our long-term outlook and GBX 600/USD 36 fair value estimate unchanged, Rentokil shares appeal. An attractive entry point into the wide-moat stock currently exists with shares trading at an approximate 15% discount to our valuation.
As we’ve previously posited, we think the softening global economic outlook represents a modest dampener to Rentokil’s organic growth throughout the remainder of 2023 and into 2024. Still, we view the softened economic conditions as a transitory headwind and expect global growth to rebound solidly in 2025.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.